Clinical Trial Update: Radiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiochemotherapy followed by gemcitabine-based adjuvant chemotherapy for cervical cancer; the study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Uterine Cervical Cancer | Phase 2 | Status: TERMINATED